ASTM E 2363 : 2014 : REDLINE
Current
The latest, up-to-date edition.
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry
English
14-01-2015
CONTAINED IN VOL. 13.01, 2016 Defines process analytical technology in the pharmaceutical industry. Terms are defined as they are used relative to the PAT framework in the pharmaceutical industry.
Committee |
E 55
|
DocumentType |
Redline
|
Pages |
10
|
PublisherName |
American Society for Testing and Materials
|
Status |
Current
|
1.1This terminology covers process analytical technology in the pharmaceutical industry. Terms are defined as they are used relative to the PAT framework in the pharmaceutical industry. Terms that are generally understood and in common usage or adequately defined in other readily available eferences are not included except where particular delineation to process analytical technology may be more clearly stated.
1.2This terminology is therefore intended to be selective of terms used generally in process analytical technology as it is applied in the pharmaceutical industry and published in a number of documents, such as those listed in the succeeding sections. The listing is also intended to define terms that appear prominently within other related ASTM standards and do not appear elsewhere.
1.3The definitions are substantially identical to those published by the U.S. Food and Drug Administration and other authoritative bodies, such as ISO, IEC, ITU, and national standards organizations.
1.4This terminology supplements current documents on terminology that concentrate on process analytical technology as it is applied in the pharmaceutical industry.
1.5An increasing number of product designations and designations for chemical, physical, mechanical, analytical, and statistical tests and standards are coming into common usage in the literature, regulatory environment, and commerce associated with process analytical technology in the pharmaceutical industry. Section 2 lists those documents referenced in this terminology.
1.6The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
ASTM E 3077 : 2017 | Standard Guide for Raw Material eData Transfer from Material Suppliers to Pharmaceutical & Biopharmaceutical Manufacturers |
ASTM E 3077 : 2017 : EDT 1 | Standard Guide for Raw Material eData Transfer from Material Suppliers to Pharmaceutical & Biopharmaceutical Manufacturers |
ASTM E 2810:2011 | Standard Practice for Demonstrating Capability to Comply with the Test for Uniformity of Dosage Units |
ASTM E 2882 : 2012 | Standard Guide for Analysis of Clandestine Drug Laboratory Evidence |
ASTM E 2476 : 2016 : REDLINE | Standard Guide for Risk Assessment and Risk Control as it Impacts the Design, Development, and Operation of PAT Processes for Pharmaceutical Manufacture |
ASTM E 3051 : 2016 | Standard Guide for Specification, Design, Verification, and Application of Single-Use Systems in Pharmaceutical and Biopharmaceutical Manufacturing |
ASTM E 2810 : 2011 : R2017 | Standard Practice for Demonstrating Capability to Comply with the Test for Uniformity of Dosage Units |
ASTM E 2891 : 2013 | Standard Guide for Multivariate Data Analysis in Pharmaceutical Development and Manufacturing Applications |
ASTM E 2810 : 2011 : EDT 1 | Standard Practice for Demonstrating Capability to Comply with the Test for Uniformity of Dosage Units |
ASTM E 2500 : 2013 : REDLINE | Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment |
ASTM E 2537 : 2016 : REDLINE | Standard Guide for Application of Continuous Process Verification to Pharmaceutical and Biopharmaceutical Manufacturing |
ASTM E 2968 : 2014 | Standard Guide for Application of Continuous Processing in the Pharmaceutical Industry |
ASTM E 2629 : 2011 | Standard Guide for Verification of Process Analytical Technology (PAT) Enabled Control Systems |
ASTM E 2810 : 2011 : EDT 2 | Standard Practice for Demonstrating Capability to Comply with the Test for Uniformity of Dosage Units |
ASTM E 2656 : 2016 : REDLINE | Standard Practice for Real-time Release Testing of Pharmaceutical Water for the Total Organic Carbon Attribute |
ASTM E 2629 : 2011 | Standard Guide for Verification of Process Analytical Technology (PAT) Enabled Control Systems |
CFR 21(PTS200-299) : 0 | FOOD AND DRUGS - FOOD AND DRUG ADMINISTRATION, CHAPTER 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES - PARTS 200-299 |
ASTM E 1564 : 2000 | Standard Guide for Design and Maintenance of Low-Temperature Storage Facilities for Maintaining Cryopreserved Biological Materials |
ASTM E 1126 : 1994 : REV A | Standard Terminology Relating to Biomass Fuels (Withdrawn 2003) |
ASTM E 869 : 1993 : R2006 | Standard Test Method for Performance Evaluation of Fuel Ethanol Manufacturing Facilities (Withdrawn 2009) |
ASTM E 1566 : 2000 | Standard Guide for Handling Hazardous Biological Materials in Liquid Nitrogen |
ISO/IEC Guide 51:2014 | Safety aspects — Guidelines for their inclusion in standards |
ASTM E 2500 : 2013 : REDLINE | Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment |
CFR 21(PTS300-499) : 0 | FOOD AND DRUGS - FOOD AND DRUG ADMINISTRATION, CHAPTER 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES - PARTS 300-499 |
EN ISO 14971:2012 | Medical devices - Application of risk management to medical devices (ISO 14971:2007, Corrected version 2007-10-01) |
ISO 9000:2015 | Quality management systems — Fundamentals and vocabulary |
ISO Guide 73:2009 | Risk management — Vocabulary |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.